C12Y 603/05002
Gmp synthase , i.e. glutamine amidotransferase
Official title: GMP synthase (glutamine-hydrolysing) (6.3.5.2), i.e. glutamine amidotransferase
C12Y603/05002 (Gmp synthase , i.e. glutamine amidotransferase) appears on 2 US grants and 6 published applications in this corpus.
Search patents in C12Y- Granted patents
- 2
- Published applications
- 6
- Assignees
- 6
- Inventors
- 24
- Latest grant
- 1 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 1 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 2 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 2 |
| 2024 | 0 | 1 |
| 2025 | 0 | 0 |
| 2026 | 1 | 0 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Novel glutamine-hydrolyzing gmp synthase variant and method for producing purine nucleotide by using same27 Jun 2024US 2024/0209342 A1Cj Cheiljedang Corporation
- Recombinant host cells to produce anthranilic acid21 Dec 2023US 2023/0407351 A1Pili
- Methods of controlling bodyweight by modulating phosphatidylinositol 5-phosphate 4-kinase beta activity30 Mar 2023US 2023/0096781 A1University of Cincinnati
- Peptide inhibitors of cd40l signaling and uses therefor10 Oct 2013US 2013/0266605 A1Phylogica Limited
- Pharmaceutical composition for the treatment of chlamydial infection9 May 2013US 2013/0116302 A1MAX-PLANCK-GESELLSCHAFT zur FOERDERUNG der WISSENSCHAFTEN.e.V
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.